Epidemiology and Trends of Mortality from prostate cancer in Iran

Document Type : Original Article (s)

Authors

1 MSc Student, Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

2 MSc Student, Department of Epidemiology and Biostatistics, School of Public Health, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Researcher, Minimally Invasive Surgery Research Center, Iran University of Medical Sciences AND PhD Student, Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Background: Prostate cancer is the second leading cause of death in men and the eighth cause of cancer death in the world. According to state of the disease in Iranian men, it is necessary to understand the epidemiology and trends of deaths from this cancer. This study aimed to investigate the epidemiology of prostate cancer trends of mortality from it in Iran.Methods: In this cross-sectional study, published data were used to relate to the face of death in the Iran. The data of prostate cancer mortality during 2005-2010 were extracted and trends of mortality of this cancer were demonstrated in the Iran.Findings: The death rate from prostate cancer had increased from 2.67 per hundred thousand people in 2005 to 3.24 in 2010. The mortality rates of prostate cancer increased with increasing in age in all the years of the study.Conclusion: Death from prostate cancer in Iran, like other countries in the world, occurs in older men and the mortality rate increases with increasing in age. Trends of mortality from prostate cancer are increasing; changes in recent years are consistent with studies in other Asian countries. Due to the aging of the Iranian population, developing one screening program for men is the way for prevention of prostate cancer progression and reducing mortality of this cancer.

Keywords

References

  1. Zahir ST, Nazemian MR, Zand S, Zare S. Survival of patients with prostate cancer in Yazd, Iran. Asian Pac J Cancer Prev 2014; 15(2): 883-6.
  2. Jemal A, Manager S, Epidemiologist JX, Ward E, President V. Cancer statistics. CA: A Cancer Journal for Clinicians 2010; 60(5): 277-300.
  3. Jemal A, Center MM, de Santis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev 2010; 19(8): 1893-907.
  4. Khakpour GH, Noorbala H, Eskandari A, Hoseinkhani A. Invasive and advanced prostate cancer in men below 45 years: Report of two cases. Kowsar Medical Journal 2000; 7(1): 12. [In Persian].
  5. Carter HB, Piantadosi S, Isaacs JT. Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 1990; 143(4): 742-6.
  6. Haghighi F, Habibi A, Tavakoli MR. Epidemiologic retrospective study of neoplasms of prostate gland in Birjand (South Khorasan province). J Birjand Univ Med Sci 2005; 12(1-2): 67-73. [In Persian].
  7. Tanagho E, McAninch J. Smith's general urology. 17th ed. New York, NY: McGraw-Hill; 2007.
  8. Baade PD, Youlden DR, Krnjacki LJ. International epidemiology of prostate cancer: geographical distribution and secular trends. Mol Nutr Food Res 2009; 53(2): 171-84.
  9. Bray F, Lortet-Tieulent J, Ferlay J, Forman D, Auvinen A. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer 2010; 46(17): 3040-52.
  10. Kvale R, Moller B, Angelsen A, Dahl O, Fossa SD, Halvorsen OJ, et al. Regional trends in prostate cancer incidence, treatment with curative intent and mortality in Norway 1980-2007. Cancer Epidemiol 2010; 34(4): 359-67.
  11. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85(1): 60-7.
  12. American Cancer Society. Cancer facts and figures. Atlanta, GA: American Cancer Society Inc; 2003.
  13. Askari F, Kardoust Parizi M, Rashidkhani B. Dietary patterns and prostate cancer: A case-control study. Iran J Nutr Sci Food Technol 2013; 8(3): 17-25. [In Persian].
  14. Mousavi SM. Toward prostate cancer early detection in Iran. Asian Pac J Cancer Prev 2009; 10(3): 413-8.
  15. Naghavi M. Portrait of deaths in 23 provinces in 2003. Tehran, Iran: Ministry of Health and Medical Education; 2005. [In Persian].
  16. Mousavi SM, Gouya MM, Ramazani R, Davanlou M, Hajsadeghi N, Seddighi Z. Cancer incidence and mortality in Iran. Ann Oncol 2009; 20(3556): 63.
  17. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991; 324(17): 1156-61.
  18. Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA. Campbell-Walsh urology. Philadelphia, PA: Saunders; 2007.
  19. Centers for Disease Control and Prevention (CDC). Trends in aging--United States and worldwide. MMWR Morb Mortal Wkly Rep 2003; 52(6): 101-4, 106.
  20. Lunenfeld B. The ageing male: demographics and challenges. World J Urol 2002; 20(1): 11-6.
  21. Khosravi A, Aghamohamadi S, Kazemi E, Pour Malek F, Shariati M. Mortality profile in Iran (29 provinces) over the years 2006 to 2010 . Tehran, Iran: Ministry of Health and Medical Education; 2013. [In Persian].
  22. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69-90.
  23. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12): 2893-917.
  24. Crawford ED. Epidemiology of prostate cancer. Urology 2003; 62(6 Suppl 1): 3-12.
  25. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59(4): 225-49.
  26. Bouchardy C, Fioretta G, Rapiti E, Verkooijen HM, Rapin CH, Schmidlin F, et al. Recent trends in prostate cancer mortality show a continuous decrease in several countries. Int J Cancer 2008; 123(2): 421-9.
  27. Bartsch G, Horninger W, Klocker H, Reissigl A, Oberaigner W, Schonitzer D, et al. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria. Urology 2001; 58(3): 417-24.
  28. Welch HG, Albertsen PC. Prostate cancer diagnosis and treatment after the introduction of prostate-specific antigen screening: 1986-2005. J Natl Cancer Inst 2009; 101(19): 1325-9.
  29. Mirzaei M, Shams M. Elderly population in the censuses of 2006. Salmand Iran J Ageing 2007; 2(5): 326-32. [In Persian].
Journal of Isfahan Medical School
Volume 33, Issue 330 - Serial Number 330
March and April 2015
Pages 515-521

Files

History

  • Receive Date: 03 January 2015
  • Revise Date: 01 November 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics